Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.2950
-0.0100 (-3.28%)
Oct 27, 2026, 3:12 PM AEDT
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 40.45 million as of October 27, 2026. It is the 34,051st most valuable company in the world and the 834th biggest in Australia. Its market cap has decreased by 25.05% in one year.
Market Cap
40.45M
Enterprise Value
34.22M
Revenue
1.72M
Global Rank
Country Rank
#834 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 40.45M, an increase of 57.39%. That is a compound annual growth rate of 15.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 40.45M | -51.15% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saluda Medical | 65.53M |
| SomnoMed | 62.63M |
| Epiminder | 57.42M |
| Compumedics | 47.94M |
| Cyclopharm | 47.15M |
| Nova Eye Medical | 42.74M |
| HeraMED | 41.71M |
| Micro-X | 39.13M |